{"name": "Aastrom Biosciences",
 "permalink": "aastrom-biosciences",
 "crunchbase_url": "http://www.crunchbase.com/company/aastrom-biosciences",
 "homepage_url": "http://www.aastrom.com/",
 "blog_url": "http://www.aastrom.com/blog/",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1989,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "mail@aastrom.com",
 "phone_number": "734-418-4400",
 "description": "",
 "created_at": "Tue Mar 13 03:38:39 UTC 2012",
 "updated_at": "Tue Mar 13 03:49:00 UTC 2012",
 "overview": "\u003Cp\u003EAastrom Biosciences is dedicated to the development of treatments for critical cardiovascular diseases. Aastrom is currently evaluating its autologous cellular therapies in late-stage U.S. clinical trials in the treatment of critical limb ischemia (CLI) and dilated cardiomyopathy (DCM). These critical diseases are associated with significant morbidity and mortality and very limited treatment options.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       59],
      "assets/images/resized/0017/7872/177872v1-max-150x150.jpg"],
     [[223,
       89],
      "assets/images/resized/0017/7872/177872v1-max-250x250.jpg"],
     [[223,
       89],
      "assets/images/resized/0017/7872/177872v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chief Executive Officer, President, and Director",
    "person":
     {"first_name": "Timothy",
      "last_name": "M. Mayleben",
      "permalink": "timothy-m-mayleben",
      "image":
       {"available_sizes":
         [[[110,
            121],
           "assets/images/resized/0017/7874/177874v1-max-150x150.jpg"],
          [[110,
            121],
           "assets/images/resized/0017/7874/177874v1-max-250x250.jpg"],
          [[110,
            121],
           "assets/images/resized/0017/7874/177874v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Chief Scientific Officer",
    "person":
     {"first_name": "Ronnda",
      "last_name": "L. Bartel",
      "permalink": "ronnda-l-bartel",
      "image":
       {"available_sizes":
         [[[110,
            121],
           "assets/images/resized/0017/7876/177876v1-max-150x150.jpg"],
          [[110,
            121],
           "assets/images/resized/0017/7876/177876v1-max-250x250.jpg"],
          [[110,
            121],
           "assets/images/resized/0017/7876/177876v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "CEO / President / Director",
    "person":
     {"first_name": "Tim",
      "last_name": "Mayleben",
      "permalink": "tim-mayleben",
      "image":
       {"available_sizes":
         [[[114,
            150],
           "assets/images/resized/0026/7086/267086v1-max-150x150.jpg"],
          [[190,
            250],
           "assets/images/resized/0026/7086/267086v1-max-250x250.jpg"],
          [[200,
            263],
           "assets/images/resized/0026/7086/267086v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Board Member",
    "person":
     {"first_name": "Tim",
      "last_name": "Mayleben",
      "permalink": "tim-mayleben",
      "image":
       {"available_sizes":
         [[[114,
            150],
           "assets/images/resized/0026/7086/267086v1-max-150x150.jpg"],
          [[190,
            250],
           "assets/images/resized/0026/7086/267086v1-max-250x250.jpg"],
          [[200,
            263],
           "assets/images/resized/0026/7086/267086v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$40M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://finance.yahoo.com/news/aastrom-biosciences-completes-40-million-160000000.html",
    "source_description": "Aastrom Biosciences Completes $40 Million Financing",
    "raised_amount": 40000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 3,
    "funded_day": 9,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Eastern Capital",
         "permalink": "eastern-capital",
         "image":
          {"available_sizes":
            [[[150,
               37],
              "assets/images/resized/0026/1306/261306v1-max-150x150.png"],
             [[250,
               62],
              "assets/images/resized/0026/1306/261306v1-max-250x250.png"],
             [[317,
               79],
              "assets/images/resized/0026/1306/261306v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "24 Frank Lloyd Wright Drive",
    "address2": "",
    "zip_code": "48105",
    "city": "Ann Arbor",
    "state_code": "MI",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        105],
       "assets/images/resized/0017/7873/177873v1-max-150x150.jpg"],
      [[250,
        176],
       "assets/images/resized/0017/7873/177873v1-max-250x250.jpg"],
      [[450,
        317],
       "assets/images/resized/0017/7873/177873v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}